Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
recruiting133%
terminated133%

Recent Activity

1 active trials
Showing 3 of 3
completednot_applicable

Early Versus Delayed Ileostomy Closure Following Bowel Surgery: A Randomized Controlled Trial

NCT07754227
recruitingnot_applicable

Early Ileostomy Closure for Rectal Cancer Patients in North America

NCT05027737
terminatednot_applicable

Early Closure Versus Conventional Closure in Postoperative Patients With Low Anteriresection for Rectal Cancer

NCT03746353

Clinical Trials (3)

Showing 3 of 3 trials
NCT07754227Not Applicable

Early Versus Delayed Ileostomy Closure Following Bowel Surgery: A Randomized Controlled Trial

Completed
NCT05027737Not Applicable

Early Ileostomy Closure for Rectal Cancer Patients in North America

Recruiting
NCT03746353Not Applicable

Early Closure Versus Conventional Closure in Postoperative Patients With Low Anteriresection for Rectal Cancer

Terminated

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3